Pill for breast cancer diagnosis may outperform mammograms
Researchers are developing a pill that makes tumours light up when exposed to infrared light...
List view / Grid view
Researchers are developing a pill that makes tumours light up when exposed to infrared light...
Researchers have used computer modelling to find an existing investigational drug compound for leukaemia patients to treat triple negative breast cancer...
Researchers are testing the use of pulsed sound waves to direct and focus cancer drug therapies...
A new study has found a blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests...
An MRI technique that requires no contrast agent, combined with sophisticated data analysis, could reduce the number of unnecessary breast biopsies...
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence...
Scientists have developed a new optical imaging system that uses red and near-infrared light to identify breast cancer patients who will respond to chemotherapy...
Bursting oxygen-filled microbubbles in breast cancer makes tumours three times more sensitive to radiation therapy in preliminary tests with animal models of the disease...
The FDA has expanded the approved use of Lynparza to include the treatment of patients with metastatic breast cancer who have a BRCA gene mutation...
A new study suggests breast cancer patients taking palbociclib/letrozole combination therapy should avoid foods rich in xenoestrogens...
Kisqali receives breakthrough therapy designation for initial endocrine-based treatment of pre- or perimenopausal women with HR+/HER2- advanced or metastatic breast cancer...
Researchers have developed tiny drug-laden nanoparticles that can seek and destroy cancer stem cells...
NICE recommends Kisqali as a cost-effective treatment option for postmenopausal women within England and Wales with advanced breast cancer...
In vitro study verifies method for remotely triggering release of cancer drugs...
Patients with advanced breast cancer who are treated with a combination of drugs are at increased risk of suffering adverse side effects...